Cargando…
CD34 and p53 Immunohistochemical Stains Differentiate Hypocellular Myelodysplastic Syndrome (hMDS) from Aplastic Anemia and a CD34 Immunohistochemical Stain Provides Useful Survival Information for hMDS
BACKGROUND: The presence of significant dysplasia in bone marrow (BM) aspirates helps to distinguish between hypocellular myelodysplastic syndrome (hMDS) and aplastic anemia (AA). Occasionally, diluted BM aspirates make it difficult to recognize dysplastic changes and can also negatively affect the...
Autores principales: | Cha, Choong-Hwan, Park, Chan-Jeoung, Chi, Hyun-Sook, Seo, Eul Ju, Jang, Seongsoo, Cho, Young-Uk, Lee, Kyoo-Hyung, Lee, Je-Hwan, Lee, Jung-Hee, Im, Ho Joon, Seo, Jong-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Laboratory Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215417/ https://www.ncbi.nlm.nih.gov/pubmed/25368817 http://dx.doi.org/10.3343/alm.2014.34.6.426 |
Ejemplares similares
-
Azacytidine Failure Revisited: an Appraisal Based on Real-Life Data from the MDS Registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS)
por: Kotsianidis, Ioannis, et al.
Publicado: (2019) -
Clinical Relevance of p53 Immunohistochemical Stain in the Differential Diagnosis Between Pediatric Aplastic Anemia and Refractory Cytopenia of Childhood
por: Park, Sang Hyuk, et al.
Publicado: (2016) -
Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS Patients
por: Chandra, Dinesh, et al.
Publicado: (2017) -
Cutaneous Syncytial Myoepithelioma with Positive CD34 Immunohistochemical Staining: An Unusual Tumor and a Challenging Diagnosis
por: Ariasi, Cesare, et al.
Publicado: (2023) -
Ber-H2 (CD30) Immunohistochemical Staining of Human Fetal Tissues
por: Tamiolakis, D, et al.
Publicado: (2005)